DEFINITION of neovascularization

Neovascularization refers to the process where new, functional microvascular networks form. While it can be a normal physiological response (such as in wound healing or the female reproductive cycle), in the context of medical coding and pathology, it is most often documented as an abnormal, disease-causing process. Pathological neovascularization is a hallmark of several severe conditions, most notably Proliferative Diabetic Retinopathy (PDR), wet (neovascular) Age-Related Macular Degeneration (AMD), neovascular glaucoma, and the growth of malignant neoplasms. These new vessels are typically fragile, poorly formed, and prone to leakage and hemorrhage, leading to tissue damage, scarring, or vision loss.


ETYMOLOGY of neovascularization

greek - (nē″ō-văs″kū-lă-rĭ-zā′shŭn ) neo-: From Greek neos, meaning “new.”

  • o: From Latin vasculum, meaning “small vessel” (diminutive of vas).

  • -ar: Suffix meaning “pertaining to.”

  • -ization: Suffix meaning “the process of creating or becoming.”

  • Literal Meaning: The process of creating new small vessels.


Aliases & Related Terms

  • DR — common abbreviation

  • Diabetic Eye Disease — lay/clinical alias

  • Diabetes-Related Retinopathy — preferred term by Cleveland Clinic

  • NPDR — Nonproliferative Diabetic Retinopathy (earlier stages)

  • PDR — Proliferative Diabetic Retinopathy (advanced stage with neovascularization)

  • DME — Diabetic Macular Edema (retinal thickening at the macula, can occur at any stage)

  • PRP — Panretinal Photocoagulation (laser treatment for PDR)

  • Anti-VEGF — drug class used to treat DME/PDR (e.g., ranibizumab, bevacizumab, faricimab)

  • Microaneurysms — earliest clinical finding in DR

  • Neovascularization — hallmark of PDR; new, fragile blood vessel growth

  • Vitreous hemorrhage — complication of PDR when new vessels bleed

  • Maculopathy — broad term for any macular disease, including DME

  • Angiogenesis: Often used synonymously with neovascularization, but clinically distinct; angiogenesis refers specifically to the sprouting of new vessels from pre-existing ones, whereas neovascularization can broadly include new vessel formation from migrating endothelial cells.

  • Vasculogenesis: The de novo formation of blood vessels during embryonic development from endothelial precursor cells (angioblasts), distinct from adult neovascularization.

  • Arteriovenous Malformation (AVM): A congenital, abnormal tangle of connecting arteries and veins without an intervening capillary bed. Unlike neovascularization, this is an anatomical defect present from birth, not a new growth responding to ischemia.

  • atherosclerosis: The buildup of fats, cholesterol, and other substances in and on the artery walls. This process causes the ischemia (lack of oxygen) that ultimately triggers neovascularization as the body attempts to bypass the blocked pathways.

  • Exudate: Fluid that leaks out of blood vessels into nearby tissues. In conditions like wet AMD, neovascularization directly causes the exudates due to the fragility and high permeability of the newly formed vessels.


Coding Corner

ICD-10-CM Codes

ICD-10 codes for DR require maximum specificity: type of diabetes + stage of retinopathy + presence/absence of macular edemalaterality (1=right, 2=left, 9=unspecified). Think of it like a 7-character code-building puzzle — you need all four dimensions documented in the chart.

Type 1 Diabetes (E10.3xx)

CodeDescription
E10.311Type 1 DM w/ unspecified DR with macular edema
E10.319Type 1 DM w/ unspecified DR without macular edema
E10.3211Type 1 DM w/ mild NPDR with macular edema, right eye
E10.3212Type 1 DM w/ mild NPDR with macular edema, left eye
E10.3291Type 1 DM w/ mild NPDR without macular edema, right eye
E10.3311Type 1 DM w/ moderate NPDR with macular edema, right eye
E10.3411Type 1 DM w/ severe NPDR with macular edema, right eye
E10.3511Type 1 DM w/ PDR with macular edema, right eye
E10.3521Type 1 DM w/ PDR with traction retinal detachment involving macula, right eye
E10.3551Type 1 DM w/ stable PDR, right eye

Type 2 Diabetes (E11.3xx)

CodeDescription
E11.311Type 2 DM w/ unspecified DR with macular edema
E11.319Type 2 DM w/ unspecified DR without macular edema
E11.3211Type 2 DM w/ mild NPDR with macular edema, right eye
E11.3291Type 2 DM w/ mild NPDR without macular edema, right eye
E11.3311Type 2 DM w/ moderate NPDR with macular edema, right eye
E11.3411Type 2 DM w/ severe NPDR with macular edema, right eye
E11.3511Type 2 DM w/ PDR with macular edema, right eye
E11.3549Type 2 DM w/ PDR with combined traction & rhegmatogenous RD, unspecified eye
E11.3551Type 2 DM w/ stable PDR, right eye
E11.3591Type 2 DM w/ PDR without macular edema, right eye

💡 Coder’s Tip: Always query the provider for laterality and stage — unspecified codes like E11.319 are valid but lower specificity and can flag for payer audits, especially for HCC risk-adjustment purposes.


CPT Codes

CPT CodeDescription
CPT CodeDescription
92004Ophthalmological exam, new patient, comprehensive (includes dilation)
92014Ophthalmological exam, established patient, comprehensive
92134OCT — scanning ophthalmic imaging, posterior segment (retina)
92250Fundus photography
92228Remote imaging for detection of retinal disease, interpretation & report
67028Intravitreal injection (e.g., anti-VEGF agents like Eylea, Lucentis)
67210Photocoagulation, focal; for focal macular edema
67228Panretinal photocoagulation (PRP), laser; for PDR

💡 Coder’s Tip: When billing the dilated diabetic eye exam, payers often prefer 92002-92014 (ophthalmological service codes) over 99xxx E/M codes for retinopathy-specific monitoring visits. Always check individual payer policies.



Med roots Appendix A Prefixes Appendix B Combining Forms Appendix C Suffixes Appendix D Suffix forms